Top Suppliers:I want be here


265114-54-3

265114-54-3 structure
265114-54-3 structure
  • Name: Telomestatin
  • Chemical Name: (±)-Telomestatin
  • CAS Number: 265114-54-3
  • Molecular Formula: C26H14N8O7S
  • Molecular Weight: 582.504
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage Telomerase
  • Create Date: 2017-02-21 00:12:42
  • Modify Date: 2024-01-02 21:19:18
  • Telomestatin is a very potent telomerase inhibitor and can be isolated from Streptomyces anulatus 3533-SV4. Telomestatin selectively facilitates the formation of intramolecular G-quadruplexes, in particular, that produced from the human telomeric sequence d[T2AG3]4. Telomestatin is an ADC cytotoxin and can be used for cancer research[1].

Name (±)-Telomestatin
Synonyms 4,8-Dimethyl-3,7,11,15,19,23,27-heptaoxa-31-thia-33,34,35,36,37,38,39,40-octaazanonacyclo[28.2.1.1.1.1.1.1.1.1]tetraconta-2(40),4,6(39),8,10(38),12,14(37), 16,18(36),20,22(35),24,26(34),28,30(33)-pentadecaene
(1<sup>2</sup>Z,2<sup>2</sup>Z,3<sup>2</sup>Z,4<sup>2</sup>Z,5<sup>2</sup>Z,6<sup>2</sup>Z,7<sup>2</sup>Z,8<sup>2</sup>Z)-6<sup>5</sup>,7<sup>5</sup>-dimethyl-8<sup>4</sup>,8<sup>5</sup>-dihydro-1(2,4),2,3,4,5,6,7(4,2)-heptaoxazola-8(2,4)-thiazolacyclooctaphane
3,7,11,15,19,23,27-Heptaoxa-31-thia-33,34,35,36,37,38,39,40-octaazanonacyclo[28.2.1.1.1.1.1.1.1.1]tetraconta-2(40),4,6(39),8,10(38),12,14(37),16,18(36),20, 22(35),24,26(34),28,30(33)-pentadecaene, 4,8-dimethyl-
Telomestatin
Description Telomestatin is a very potent telomerase inhibitor and can be isolated from Streptomyces anulatus 3533-SV4. Telomestatin selectively facilitates the formation of intramolecular G-quadruplexes, in particular, that produced from the human telomeric sequence d[T2AG3]4. Telomestatin is an ADC cytotoxin and can be used for cancer research[1].
Related Catalog
Target

Traditional Cytotoxic Agents

In Vitro Telomestatin (0-50 μM) promotes or stabilizes the formation of the intramolecular G-quadruplex. At the DNA concentrations of 0.005 and 0.2 µM, EC50 values of 0.03 µM and 0.53 µM telomestatin are found. In a parallel experiment with the mutated oligonucleotide d[T2AGAG]4, there is no conversion of the mutated sequence to a G-quadruplex structure by telomestatin[1]. Telomestatin (2-10 μ M) effects the expression of DN-hTERT on telomerase activity and telomere length, at 10 μM,the expression of DN-hTERT shows a significant reduction of telomerase activity. Additionally, at 2 μM , the terminal restriction fragment (TRF) length of U937 cells shortens progressively from 9.5 to 3.8 kb at population doubling (PD) 20 in U937 cells[2]. Telomestatin (2-5 μM; short-time or long trem) has less effect on normal diploid human fibroblasts and ALT-positive cells[2]. Telomestatin (5 μM; short-time 3 days) exposure has no affect the viability of normal human fibroblasts BJ or IMR-90; however, 5 μ M of telomestatin reduces the viability of GM847 cells[2]. Telomestatin (2 μM; long-term 10-50 days) does not significantly change the proliferation rate or viability to that of control cells in BJ or IMR-90 cells and also does not change the proliferation of GM847 cells[2].
In Vivo Telomestatin ( intraperitoneal injection; 3-15 mg/kg; two times a week; 4 weeks) decreases tumor telomerase activity and inhibits the growth of U937 xenografts. Systemic administrations of 3 mg/kg or 9 mg/kg or 15 mg/kg of telomestatin decreases tumor telomerase activity by 60.2%, 74% and 92.5% compared to control, respectively[2]. Animal Model: Mice model with U937 xenografts[2] Dosage: 3-15 mg/kg Administration: Intraperitoneal injection; 3-15 mg/kg; two times a week; 4 weeks Result: Treated with PBS for 21 days had a mean tumor volume of 1395 mm3 compared with telomestatin treated with a mean tumor volume of 291 mm3. Exhibited no adverse effects (body weight loss, clinical signs or survival). Reduced U937 cells in bone marrow and recovered the normal hematopoiesis in mice.
References

[1]. Mu-Yong Kim, et al. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J Am Chem Soc. 2002 Mar 13;124(10):2098-9.

[2]. Keita Amagai, et al. Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host. Sci Rep. 2017 Jun 13;7(1):3382.

[3]. T Tauchi, et al. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene. 2006 Sep 21;25(42):5719-25.

Density 2.0±0.1 g/cm3
Molecular Formula C26H14N8O7S
Molecular Weight 582.504
Exact Mass 582.070618
PSA 219.87000
LogP 0.67
Index of Refraction 1.962